Home » Poll Results » July 2023 Question of the Month

July 2023 Question of the Month

Does your organization have a strategy for Humira biosimilar launches?

Yes, well defined: 0%

We have a framework: 50%

Waiting for clarity: 0%

No: 0%

Unaware of need: 50%

November 2023 Question of the Month

CVS announced voluntary removal of some phenylephrine products from shelves. How will competing pharmacies react?

Slowly follow phenylephrine removal: 40.0%

No action – wait for FDA decision: 46.7%

Pharmacies will trim low selling inventory: 13.3%

Pharmacies will increase inventory to capture sales: 0%

What is the greatest challenge for prescription digital therapeutics?

Payer coverage: 57%

Provider willingness to prescribe: 14%

Patient acceptance of use: 0%

Distribution outside normal channels: 29%

How will Artificial Intelligence tools impact health care in 2024?

Drastic increase health provider productivity: 0%

Selective use cases and minor positive impact: 66.6%

Negative impact due to errors: 16.7%

No uptake and impact: 16.7%